Evidence map›Paper›PMID 34002021›Full record

ArticleMolecular psychiatry2021

Kidins220 deficiency causes ventriculomegaly via SNX27-retromer-dependent AQP4 degradation.

Ana Del Puerto, Julia Pose-Utrilla, Ana Simón-García, Celia López-Menéndez, Antonio J Jiménez, Eva Porlan, Luis S M Pajuelo, Guillermo Cano-García, Beatriz Martí-Prado, Álvaro Sebastián-Serrano and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 3 countries.

Ana Del PuertoInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Julia Pose-UtrillaInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Ana Simón-GarcíaInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Celia López-MenéndezInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Antonio J JiménezDepartamento de Biología Celular, Genética y Fisiología, Facultad de Ciencias, Universidad de Málaga, Bulevar Louis Pasteur, Málaga, Spain.
Eva PorlanCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Madrid, Spain.
Luis S M PajueloInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Guillermo Cano-GarcíaInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Beatriz Martí-PradoDepartmento de Biología Celular, Biología Funcional y Antropología Física, Universidad de Valencia, Burjassot, Spain.
Álvaro Sebastián-SerranoInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Marina P Sánchez-CarraleroInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain.
Fabrizia CescaDepartment of Life Sciences, University of Trieste, Trieste, Italy.
Giampietro SchiavoDepartment of Neuromuscular Disorders, UCL Institute of Neurology, University College London, London, UK.ORCID http://orcid.org/0000-0002-4319-8745
Isidro FerrerCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.ORCID http://orcid.org/0000-0001-9888-8754
Isabel FariñasCentro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Miguel R CampaneroCentro de Biología Molecular "Severo Ochoa" (CSIC-UAM), Madrid, Spain.ORCID http://orcid.org/0000-0003-1410-8621
Teresa IglesiasInstituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, Spain. tiglesias@iib.uam.es.ORCID http://orcid.org/0000-0002-4326-9005
Consejo Superior de Investigaciones Científicas · ESInstituto de Salud Carlos III · ESUniversitat de València · ESHospital Universitario La Paz · ESInstituto de Investigación Biomédica de Málaga · ESUK Dementia Research Institute · GBUniversidad Complutense de Madrid · ESUniversity of Trieste · IT

Funding

Wellcome TrustWellcome Trust 107116/Z/15/Z
6 · The paper itself

Abstract

Several psychiatric, neurologic and neurodegenerative disorders present increased brain ventricles volume, being hydrocephalus the disease with the major manifestation of ventriculomegaly caused by the accumulation of high amounts of cerebrospinal fluid (CSF). The molecules and pathomechanisms underlying cerebral ventricular enlargement are widely unknown. Kinase D interacting substrate of 220 kDa (KIDINS220) gene has been recently associated with schizophrenia and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus and obesity (SINO syndrome), diseases frequently occurring with ventriculomegaly. Here we show that Kidins220, a transmembrane protein effector of various key neuronal signalling pathways, is a critical regulator of CSF homeostasis. We observe that both KIDINS220 and the water channel aquaporin-4 (AQP4) are markedly downregulated at the ventricular ependymal lining of idiopathic normal pressure hydrocephalus (iNPH) patients. We also find that Kidins220 deficient mice develop ventriculomegaly accompanied by water dyshomeostasis and loss of AQP4 in the brain ventricular ependymal layer and astrocytes. Kidins220 is a known cargo of the SNX27-retromer, a complex that redirects endocytosed plasma membrane proteins (cargos) back to the cell surface, thus avoiding their targeting to lysosomes for degradation. Mechanistically, we show that AQP4 is a novel cargo of the SNX27-retromer and that Kidins220 deficiency promotes a striking and unexpected downregulation of the SNX27-retromer that results in AQP4 lysosomal degradation. Accordingly, SNX27 silencing decreases AQP4 levels in wild-type astrocytes whereas SNX27 overexpression restores AQP4 content in Kidins220 deficient astrocytes. Together our data suggest that the KIDINS220-SNX27-retromer-AQP4 pathway is involved in human ventriculomegaly and open novel therapeutic perspectives.

Indexed as

HydrocephalusAnimalsAquaporin 4EpendymaHumansLysosomesMembrane ProteinsMiceNerve Tissue ProteinsSorting NexinsAqp4 protein, mouseAquaporin 4KIDINS220 protein, humanKidins220 protein, mouseMembrane ProteinsNerve Tissue ProteinsSNX27 protein, humanSnx27 protein, mouseSorting Nexins

Identifiers

PMID34002021
PMCPMC8760065
OpenAlexW3163325471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.